1.09
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LXRX Giù?
Forum
Previsione
Frazionamento azionario
Lexicon Pharmaceuticals Inc Azioni (LXRX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
2,187%
28.87
|
1.262 | 26.55 | 1.75 | 1.647 |
Cost Of Revenue |
10.00%
0.033
|
0.03 | 0.348 | 0.071 | 0.166 |
Gross Profit |
2,240%
28.83
|
1.232 | 26.21 | 1.679 | 1.481 |
|
6.74%
25.10
|
26.91 | 58.94 | 65.37 | 56.84 |
Benefits Costs and Expenses |
6.72%
25.13
|
26.94 | 59.29 | 65.44 | 57.00 |
Costs And Expenses |
6.72%
25.13
|
26.94 | 59.29 | 65.44 | 57.00 |
Operating Income/Loss |
114.55%
3.736
|
-25.68 | -32.74 | -63.69 | -55.35 |
Income/Loss From Continuing Operations Before Tax |
114.77%
3.736
|
-25.30 | -32.74 | -63.69 | -53.43 |
Income/Loss From Continuing Operations After Tax |
112.86%
3.252
|
-25.30 | -33.77 | -64.81 | -53.43 |
|
112.86%
3.252
|
-25.30 | -33.77 | -64.81 | -53.43 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.34%
363.29
|
362.07 | 13.92 | 361.49 | 310.84 |
Diluted Average Shares |
0.41%
363.57
|
362.07 | 13.92 | 361.49 | 310.84 |
Basic Earnings Per Share |
114.29%
0.01
|
-0.07 | -0.09 | -0.18 | -0.17 |
Diluted Earnings Per Share |
114.29%
0.01
|
-0.07 | -0.09 | -0.18 | -0.17 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):